FisherVista

Crypto asset investment products attracted nearly $860 million in fresh capital last week, marking six straight weeks of positive flows as optimism over proposed U.S. regulation continues to influence market sentiment.

Microsoft is considering delaying or scrapping its 2030 goal to match hourly power consumption with clean energy purchases due to growing AI energy demands, highlighting the tension between tech expansion and climate commitments.

The disruption in the Strait of Hormuz is endangering the global electric vehicle industry by blocking transport of critical raw materials for batteries, risking production slowdowns and higher consumer prices.

The Department of Health and Human Services plans to ease safeguards for AI healthcare tools, sparking debate over the balance between innovation and patient safety.

Dogwood Therapeutics announced Q1 2026 financial results and highlighted progress in its non-opioid pain pipeline, including Phase 2b data for Halneuron expected in fall 2026 and FDA clearance for SP16 to enter Phase 1b.

LIG Assets, Inc. is working on a technical report under SEC Regulation S-K Subpart 1300 to update the valuation of its calcium carbonate mining assets in Marianna, Florida, which were previously appraised at $400 million in 2009, aiming to reflect substantial market changes and enhance transparency.

BluSky AI Inc. announced a Regulation A+ offering to raise funds for expanding its modular AI Factory footprint and Neocloud compute capacity across the United States, allowing individual and accredited investors to participate with a minimum investment of $1,000.

Aditxt (NASDAQ: ADTX) will implement a 1-for-27 reverse stock split on May 18, 2026, to meet Nasdaq’s minimum bid price requirement, reducing outstanding shares from 13.8 million to about 510,123.

SPARC AI Inc. is featured in an AINewsWire editorial discussing its software-only platform that enables drones to navigate and target without GPS, addressing critical defense needs in contested electronic warfare environments.

MindBio Therapeutics Corp. is developing an AI-driven voice analysis platform to detect drug and alcohol impairment from brief speech recordings, addressing growing demand for noninvasive, scalable intoxication detection in healthcare, workplace safety, and public health.

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results and detailed a strategic transformation toward acquiring clinical-stage neurology and oncology assets, supported by a $22.5 million private placement to fund operations and potential acquisitions.

Kairos Pharma receives the 2026 GHP Magazine Healthcare & Pharmaceutical Award for its work in developing cancer therapies that overcome drug resistance, highlighting its lead candidate ENV-105 currently in clinical trials.

SureNano Science Ltd. announced its featured BioMedWire editorial on GEP-44, a novel triple agonist peptide from its subsidiary GlucaPharm Inc., aiming to improve efficacy, tolerability, and delivery flexibility in obesity and type 2 diabetes care.

NextPlat Corp posts record gross margins and reduced losses in Q1 2026 as turnaround efforts gain traction, targeting positive operating income by H2.

American Fusion Inc. updates on strategic D.C. engagements for its Texatron Fusion Engine in defense and energy, while progressing toward OTCQB listing and 5MW pre-production unit.

Tonix Pharmaceuticals will present a poster at ISPOR 2026 analyzing real-world fibromyalgia treatment patterns following the FDA approval of TONMYA, marking the first new therapy for the condition in over 15 years.

G Mining Ventures Corp. posted record net income of $80.4 million and free cash flow of $56.2 million in Q1 2026, driven by strong margins at its Tocantinzinho mine and higher gold prices, while maintaining full-year production guidance of 160,000–190,000 ounces.

HeartBeam Inc. reported first-quarter 2026 operational and financial results, highlighting initial commercial partnerships, progress in cardiac detection initiatives, and a $11.5 million public offering, with a net loss improvement to $4.7 million.